期刊文献+

老年前列腺癌患者身体状态评估的研究进展 被引量:2

Assessment of the physical status of elderly patients with prostate cancer
下载PDF
导出
摘要 在美国,前列腺癌(PCa)已成为第一位危害男性健康的肿瘤,在我国的发病率也逐年升高,但监测与治疗还是相对落后,很多患者在就诊时已是晚期或者年龄较大;治疗方案的选择尚无统一规范,患者状态的综合评估往往不够具体或者被忽略,这样进行的治疗可能会给患者带来过多的身体、心理和经济负担,甚至造成死亡;也有过于保守的,失去了最佳的治疗时机导致患者病情加重等。所以对于老年PCa患者治疗前的身体状态综合评估应该引起重视,选择最佳的治疗方案为患者带来最大益处。 Prostate cancer (PCa) is the primary malignancy threatening meng health in the United States and its incidence is in- creasing in China year by year. Many PCa cases are found in the advanced stage or in the old age, treated with unstandardized options, with negligence of comprehensive assessment of the patient~ physical status, which may frequently add to the physical, psychological and economic burdens of the patient and even result in death. On the other hand, some excessively consepcative therapeutic options may cause the loss of the best time of management or lead to deterioration of the disease. Therefore, sufficient importance shouht be at- tached to the comprehensive assessment of the physical status of the elderly PCa patient before treatment and the choice of the best ther- apeutic protocol.
作者 刘碧天 吴斌
出处 《中华男科学杂志》 CAS CSCD 北大核心 2017年第12期1132-1137,共6页 National Journal of Andrology
关键词 前列腺癌 老年 并发症 身体状态评估 综合评估 G8 prostate cancer elderly male complications physical status evaluation comprehensive assessment Geriatric 8Questionnaire
  • 相关文献

参考文献4

二级参考文献31

  • 1赫杰,赵平,陈万青.2011中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:2-5,26 -37,74 -75.
  • 2Segi M. Cancer mortality for selected sites in 24 countries(1950-57 ) [ M ]. Japan : Department of Public Health,Tohoku Univer-sity of Medicine, 1960.
  • 3FerlayJ, Shin HR, Bray F, et al. Estimates of worldwide burdenof cancer in 2008 : GLOBOCAN 2008 [ J]. Int J Cancer, 2010,127(12) : 2893 -2917.
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin’2011,61(2) :69 -90.
  • 5Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J].CA Cancer J Clin,2012,62( 1) :10 - 29.
  • 6Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1) : 9-29.
  • 7Stokes ME, Black L, Benedict A, et al. Long-term medical-care costs related to prostate cancer: Estimates from linked SEER- Medicare data. Prostate Cancer Prostatic Dis, 2010, 13 (3) : 278 -284.
  • 8Stephan C. Prostate cancer: WHO standardization of PSA tests: Clinical consequences. Nat Rev Urol, 2009, 6(6) : 303-305.
  • 9Mikolajczyk SD, Catalona WJ, Evans CL, et al. Proenzyme forms of prostate-specific antigen in serum improves the detection of pros- tate cancer. Clin Chem, 2004, 50(6) : 1017-1025.
  • 10Raaijmakers R, Wildhagen MF, 1to K, et al, Prostate-specific antigen change in the European randomized study of screening for prostate cancer. Urology, 2004, 63 (2) : 316-320.

共引文献785

同被引文献10

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部